Abstract
No AccessJournal of UrologyAdult Urology1 May 2021Editorial CommentThis article comments on the following:Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy Vikram M. Narayan Vikram M. NarayanVikram M. Narayan Urologic Oncology, Emory University School of Medicine, Atlanta, Georgia More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001559.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, 205(5), p. 1351 Reference 1. : Genomic predictors of outcome in prostate cancer. Eur Urol 2015; 68: 1033. Google Scholar © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyDec 24, 2020, 12:00:00 AMHeterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy Volume 205Issue 5May 2021Page: 1351-1351 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Vikram M. Narayan Urologic Oncology, Emory University School of Medicine, Atlanta, Georgia More articles by this author Expand All Advertisement PDF DownloadLoading ...
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
